July 2025 | Hematology, Transfusion and Cell Therapy

Advanced Search

Share

English

Português

Home July 2025

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2025

2.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2025

0.370

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2025

0.619

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more

Time to first decision

33 days

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

Cover Vol. 47. Issue S2.

Vol. 47. Issue S2.

XVI Eurasian Hematology Oncology Congress

(July 2025)

Poster Presentations

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103878

Full text access

Share

Speech Summary

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103864

Full text access

Share

DIFFUSE LARGE CELL LYMPHOMAS WITH RESTRICTED SOURCES

Suzana Krasniqi

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103865

Full text access

Share

Oral Presentations

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103915

Full text access

Share

MISSION TO MARS: RADIATION RISKS FROM INTER-PLANETARY TRAVEL

Robert Peter Gale

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103866

Full text access

Share

THE HISTORY OF CHRONIC MYELOID LEUKEMIA (CML): FROM ARSENIC TO TYROSINE KINASE INHIBITORS (TKI)

Rüdiger Hehlmann

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103867

Full text access

Share

MDS DIAGNOSIS? STILL BY BONE MARROW EXAMINATION?

Moshe Mittelman

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103868

Full text access

Share

HOW I TREAT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA

Robin Foà

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103869

Full text access

Share

WHICH IS THE BEST TREATMENT FOR AML WITH RESTRICTED RESOURCES

Mipsang Lama

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103870

Full text access

Share

UPDATES ON HODGKIN DISEASE

Valeh Huseynov

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103871

Full text access

Share

HISTORY OF BLOOD TRANSFUSION

Tanju Atamer

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103872

Full text access

Share

TREATMENT FOR HODGKIN’S LYMPHOMAS IN COUNTRIES WITH LIMITED RESOURCES

Khalid Halahleh

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103873

Full text access

Share

CLASSIFICATION OF MPN

Haifa Kathrin Al-Ali

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103874

Full text access

Share

PREDİCTİON OF THE RİSK OF LEUKEMİA DEVELOPMENT İN AGED HEALTHY POPULATİON: IMPLEMENTATİON İN THE PUBLİC HEALTH SYSTEM

Francesco Frassoni, Roberto Tedone, Emanuela Marcenaro, Giorgio Piastra, Davide Guerr

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103875

Full text access

Share

VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML

Dmitrii Zhogolev, Nikita Pastukhov, Bella Aybova, Anna Smirnova, Ivan Moiseev, Sergey Bondarenko, Alexander Kulagin

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103876

Full text access

Share

PREDICTORS OF RESPONSE TO RUXOLITINIB THERAPY IN PATIENTS WITH MYELOFIBROSIS

Irina Turtanova, Maria Barabanshchikova, Elena Morozova, Tatiana Gindina, Tatiana Shneyder, Natalia Dorofeeva, Roman Vaschenkov, Nadezhda Medvedeva, Alexander Kulagin

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103877

Full text access

Share

A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW

Jiantuo Liu, Hongrui Li, Li Jiang, Xiangjun Chen, Yanli He

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103879

Full text access

Share

A NEW LOOK AT THE TREATMENT OF PATIENTS WITH ACUTE LEUKEMIA

MirEldar Babayev

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103880

Full text access

Share

CYTOGENETIC FEATURES OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH INTRACHROMOSOMAL AMPLIFICATION OF CHROMOSOME 21

Jiantuo Liu, Hongrui Li, Li Jiang, Ping Zhang, Shanlin Zheng, Xuekui Qiu, Haiqin Zhang

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103881

Full text access

Share

IMMUNOPHENOTYPIC CHARACTERISTICS AND TREATMENT OUTCOME OF T-ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS; AN IRAQI CENTER EXPERIENCE

Abdulsalam Al-Ani, Alaadin Sahham Naji, Luma Essa Hamodi, Alaa Fadhil Alwan

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103882

Full text access

Share

DYNAMIC BALANCE EVALUATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY

Fulya Ipek-Erdem, Sena Sonkaya, Arzu Genç, Şebnem Yılmaz

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103883

Full text access

Share

INVESTIGATION OF POSTURAL CONTROL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Fulya Ipek-Erdem, Sena Sonkaya, Arzu Genç, Şebnem Yılmaz

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103884

Full text access

Share

PROGNOSTIC VALUE OF CD56 EXPRESSION IN CHILDREN WITH ACUTE MYELOID LEUKEMIA

Reyhan Aliyeva, Azer Kerimov, Naila Iasmayil, Gunel Aliyeva

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103885

Full text access

Share

LOW DOSE CYTARABINE PLUS SORAFENIB IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA

Tural Mahmudov

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103886

Full text access

Share

OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER EXPERIENCE

Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103887

Full text access

Share

EXPERIENCE WITH TOTALLY IMPLANTABLE VENOUS ACCESS PORTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Erkan Bilgin, Ahmet Bayrak

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103888

Full text access

Share

VALIDATION OF LONG-TERM HANDLING AND STORAGE CONDITIONS FOR HEMATOPOIETIC STEM CELL PRODUCTS FOR AUTOLOGOUS TRANSPLANTS

Ahmed Al Bahrani

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103889

Full text access

Share

CLINICO-BIOLOGICAL PROFILE AND MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Vasile Musteata, Vasile Cepraga, Larisa Musteata

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103890

Full text access

Share

UNEXPECTED SPONTANEOUS REGRESSION IN CLL AFTER LETROZOLE TREATMENT: COINCIDENCE OR CONNECTION?

Ennur Ramadan, Mesut Seker, Guven Cetin

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103891

Full text access

Share

ANALYSIS OF RESPONSE TO FIRST-LINE THERAPY WITH IMATINIB IN AZERBAIJANI CML PATIENTS

Aypara Hasanova, Chingiz Asadov, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103892

Full text access

Share

OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN OLDER ADULTS TREATED IN RESOURCE-CONSTRAINED SETTINGS

Natasha Ali, Raheel Iftikhar, Zeeshan Khan, Usman Ahmed, Humera Mahmood, Zeba Aziz

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103893

Full text access

Share

METHOTREXATE-ASSOCIATED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: TWO CASE REPORTS

Yakup Unsal, Muhammed Murati, Guler Delibalta, Serdar Bedii Omay, Vildan Yazici, Nedim Polat

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103894

Full text access

Share

RITUXIMAB WITH INVOLVED FIELD IRRADIATION FOR EARLY-STAGE DIFFUSE LARGE CELL LYMPHOMA

Vera Kovalskaya, Natalya Falaleeva, Stanislav Shklyaev, Andrey Chelmakov, Ludmila Grivtsova, Marwa Abdelgawad, Ahmed Mubarek

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103895

Full text access

Share

CASES OF PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA TREATED WITH SYSTEMIC OR LOCAL THERAPY

Müzeyyen Aslı Ergözoplu, Berksoy Şahin, Ertuğrul Bayram, Esra Gökçe

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103896

Full text access

Share

CLINICAL PRESENTATION AND OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME INTRODUCTION

Jehanzeb Ur Rehman

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103897

Full text access

Share

A CASE OF FAMILIAL PORFIRIA

Laman Hamidova, Oktay Abdullayev, Zari Balaşova, Farid Mammadov

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103898

Full text access

Share

CHIC2 DELETION-ASSOCIATED HYPEREOSINOPHILIA AND SUBSEQUENT JAK2 V617F POSITIVE THROMBOCYTOSIS

Mürüvvet Seda AYDIN, Emel Isleyen, Funda Ceran, Simten Dagdas, Gulsum Ozet

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103899

Full text access

Share

LYSOZYME-INDUCED NEPHROPATHY IN CMML: A RARE BUT SIGNIFICANT COMPLICATION REQUIRING EARLY RECOGNITION AND INTERVENTION

Alfadil Haroon, Mohamed Kindawi, Ahmed S Alotaibi, Ali Debsan Alahmari, Hazzaa Alzahrani, Mansour Alfayez, syed Osman Ahmed

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103900

Full text access

Share

LANDSCAPE OF SOMATIC MUTATIONS OF MYELOPROLIFERATIVE NEOPLASMS IN PAKISTANI PATIENTS

Mehreen Ali Khan

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103901

Full text access

Share

A CASE OF THROMBOCYTOSIS AND HEMOTHORAX IN A PATIENT WITH ITP FOLLOWING ROMIPLOSTIM USE

Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103902

Full text access

Share

IMPACT OF LENALIDOMIDE MAINTENANCE DOSAGE ON SURVIVAL OUTCOMES IN MULTIPLE MYELOMA

Zeynep Kürüm, Ayfer Gedük

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103903

Full text access

Share

ASSESSMENT OF INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TEST IN A PATIENT WITH MULTIPLE MYELOMA: EXPERIENCE OF OUR MEDICAL GENETICS DEPARTMENT

Fatma Turki, Imen Rezgui, Faten Kallel, Moez Mdhaffer, Hassen Kamoun, Rim Frikha

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103904

Full text access

Share

TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER

Meryem Sener

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103905

Full text access

Share

THE SUCCESS LIES ON CLINICAL SUSPECT: THE SYNCHRONOUS CANCERS PRESENTING AS PULMONARY AND VERTEBRAL MASS LESIONS

Ulviyya Hasanzade, Metban Mastanzade, Sevgi Kalayoğlu Beşışık

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103906

Full text access

Share

ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSED FOUR YEARS AFTER HSCT IN A BETA THALASSEMIA PATIENT: A CLINICAL CASE

Samira Hasanova, Huseyn Kerimov, Avesta Allahverdiyeva, Azer Kerimov, Nargiz Aliyeva, Seher İsmayilova

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103907

Full text access

Share

INVESTIGATION OF THE RELATIONSHIP BETWEEN COMPASSION AND BURNOUT AMONG HEMATOLOGIST AND ONCOLOGIST

Nisa Aliş, Aze Buyruk, Birol Güvenç, Berksoy Şahin, Naciye Nur Tozluklu

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103908

Full text access

Share

A RARE CASE OF DIFFUSE LARGE B-CELL LYMPHOMA PRESENTING WITH CHRONIC GASTROINTESTINAL SYMPTOMS: A DIAGNOSTIC CHALLENGE

Bulut Sat, Burak Demir, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103909

Full text access

Share

ACUTE MYELOID LEUKEMIA PRESENTING AS ISOLATED MYELOID SARCOMA: A CASE REPORT

Elif Canpolat Hırfanoğlu, Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103910

Full text access

Share

COLD AGGLUTININ DISEASE IN A PATIENT WITH WALDENSTRÖM’S MACROGLOBULINEMIA: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE

Ceren Kısa, Feride Aslanca, Melisa Ural, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103911

Full text access

Share

REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT

Büşra Akdoğan, Ali Turunç, Birol Güvenç

Hematol Transfus Cell Ther. 2025;47 Supl 2: 103912

Full text access

Share

Loading more articles...

Idiomas

Hematology, Transfusion and Cell Therapy